Improved prediction of MHC-peptide binding using protein language models

Abstract

Major histocompatibility complex Class I (MHC-I) molecules bind to peptides derived from intracellular antigens and present them on the surface of cells, allowing the immune system (T cells) to detect them. Elucidating the process of this presentation is essential for regulation and potential manipulation of the cellular immune system. Predicting whether a given peptide binds to an MHC molecule is an important step in the above process and has motivated the introduction of many computational approaches to address this problem. NetMHCPan, a pan-specific model for predicting binding of peptides to any MHC molecule, is one of the most widely used methods which focuses on solving this binary classification problem using shallow neural networks. The recent successful results of Deep Learning (DL) methods, especially Natural Language Processing (NLP-based) pretrained models in various applications, including protein structure determination, motivated us to explore their use in this problem. Specifically, we consider the application of deep learning models pretrained on large datasets of protein sequences to predict MHC Class I-peptide binding. Using the standard performance metrics in this area, and the same training and test sets, we show that our models outperform NetMHCpan4.1, currently considered as the-state-of-the-art.

Exploring the Function of Predicted T‐Cell Epitopes in Enhancing Influenza Virus Vaccine Efficacy

“…Propred 1 server was using for the MHC Class I, which allowed to predict about 47 alleles and threshold value was 4% with proteosome filter 3%. [ 45,46 ] STEP:‐3 . Analysis for conserved sequences in both the strain H1N1 and H5N1 …”

A Computational Pipeline for Accurate Prioritization of Protein‐Protein Binding Candidates in High‐Throughput Protein Libraries

“…As the field advances, we expect to see better AI methods that coupled with this strategy, will lead to better predictions. [53,54] Finally, as interest in peptides as potential drugs increases, so does the ability of AI software to handle peptide cyclizations, [55,56] which results in improved membrane permeability and increased resistance to degradation.…”

Editorial: Experts' opinion in medicine 2022

“…Artificial-intelligence-based approaches are supposed to promote the translation of basic research to medicine by providing a better understanding of the disease- or drug-affected pathways ( 15 , 16 ), particularly those assessed by modern imaging techniques ( 17 – 20 ). Artificial intelligence may also help patients to learn more about their diseases and the needed control measures.…”